Quetiapine in the treatment of the Gilles de la Tourette syndrome. A case study

In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Tijdschrift voor psychiatrie 2007, Vol.49 (4), p.263
Hauptverfasser:	Neves Ramos, D, van West, D, van Strien, A P M
Format:	Artikel
Sprache:	dut
Schlagworte:	Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Child Dibenzothiazepines - adverse effects Dibenzothiazepines - therapeutic use Humans Male Quetiapine Fumarate Safety Tourette Syndrome - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this article we describe the clinical response of an 8-year-old boy with the Gilles de la Tourette syndrome (GTS) when treated with quetiapine. Upon admission for observation he received a trial course of quetiapine, to which he responded favourably. We searched the Medline and Psycinfo databases for information about the recommended dose of quetiapine for children with GTS. From the 12 case-studies and one open-label trial that we found, we conclude that the maximum dose of quetiapine for children with GTS is 200 mg. Data concerning the safety of quetiapine when administered to children are limited and contradictory.
ISSN:	0303-7339